Cadila Healthcare Limited

Cadila Healthcare Limited (India) holds 0 active US FDA Type II Drug Master Files and 57 inactive and has DMF or CEP filings on record for 40 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Cadila Healthcare Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/cadila-healthcare-limited

Overview

Cadila Healthcare Limited, commonly known as Zydus Cadila, is one of the leading pharmaceutical companies in India. The company is involved in the discovery, development, manufacturing, and marketing of a wide range of healthcare products. Known for its innovative treatments and significant investment in research and development, Zydus Cadila plays a pivotal role in global healthcare.

Core services & business areas

Pharmaceutical ManufacturingResearch and DevelopmentRegulatory AffairsSales and MarketingAPI ManufacturingMarketing AuthorizationPharmaceutical Distribution

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Cadila Healthcare Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Cadila Healthcare Limited holds 0 active (57 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • IMATINIB MESYLATE (AMORPHOUS)Inactive2013-12-18
  • ARSENIC TRIOXIDEInactive2013-09-23
  • SALMETEROL XINAFOATE USPInactive2012-02-16
  • IRBESARTAN USPInactive2011-11-12
  • DESVENLAFAXINE BASEInactive2011-10-22
  • ERLOTINIB HYDROCHLORIDE (FORM-B)Inactive2011-10-02
  • PALIPERIDONEInactive2011-04-30
  • ESOMEPRAZOLE SODIUMInactive2011-01-07
  • DICLOFENAC EPOLAMINEInactive2011-01-04
  • CAPECITABINE USPInactive2011-01-03
  • DULOXETINE HYDROCHLORIDE USP (DUB ROUTE)Inactive2010-10-13
  • IRINOTECAN HYDROCHLORIDE USPInactive2010-07-20
  • SOLIFENACIN SUCCINATEInactive2010-04-05
  • CLOPIDOGREL BISULFATE USP (FORM-I) (CUE ROUTE)Inactive2010-01-07
  • RANOLAZINEInactive2010-01-06
  • GEMCITABINE HYDROCHLORIDE USPInactive2010-01-06
  • ATORVASTATIN CALCIUM (CRYSTALLINE)Inactive2009-11-11
  • ESCITALOPRAM OXALATE (FORM -1)Inactive2009-10-23
  • OXALIPLATIN PH EURInactive2009-09-10
  • ATORVASTATIN CALCIUM (CRYSTALLINE FORM I)Inactive2009-07-31
  • PREGABALINInactive2009-07-08
  • VENLAFAXINE HYDROCHLORIDE PH EURInactive2009-03-31
  • VALSARTAN USPInactive2009-03-31
  • TRAMADOL HYDROCHLORIDEInactive2009-03-31
  • ANASTROZOLEInactive2008-12-17
  • CARVEDILOL (FORM II)Inactive2008-09-30
  • ZALEPLONInactive2008-04-01
  • PROGUANIL HYDROCHLORIDE USPInactive2008-03-26
  • LETROZOLE USPInactive2008-03-25
  • Quetiapine FumarateInactive2008-01-03
  • Rabeprazole Sodium (Amorphous)Inactive2007-12-20
  • CLOPIDOGREL BISULFATE USP (FORM-I)Inactive2007-07-06
  • CSA SALT OF CLOPIDOGRELInactive2007-06-11
  • MEMANTINE HYDROCHLORIDEInactive2007-03-30
  • ALFUZOSIN HYDROCHLORIDEInactive2007-03-28
  • SIMVASTATIN (AMMONIUM SALT ROUTE)Inactive2007-03-26
  • SIMVASTATIN ( LOVASTATIN ROUTE)Inactive2007-01-08
  • DULOXETINE HYDROCHLORIDE USPInactive2006-07-25
  • BUPROPION HYDROCHLORIDEInactive2006-03-28
  • GLYBURIDEInactive2006-03-10
  • ZOLPIDEM TARTRATEInactive2006-03-03
  • OLANZAPINEInactive2006-02-10
  • ZIPRASIDONE HYDROCHLORIDE ANHYDROUSInactive2005-11-11
  • OMEPRAZOLEInactive2005-07-11
  • SIMVASTATINInactive2005-03-31
  • RABEPRAZOLE SODIUMInactive2005-03-31
  • LOSARTAN POTASSIUM USPInactive2005-03-04
  • SERTRALINE HYDROCHLORIDEInactive2005-02-03
  • FLUVASTATIN SODIUMInactive2004-12-07
  • TERAZOSIN HYDROCHLORIDE ANHYDROUSInactive2004-08-16

Showing the 50 most relevant of 57 Drug Master Files (active first). The full list is in the FDA DMF list.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Cadila Healthcare Limited in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Cadila Healthcare Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.